You are viewing a single comment's thread from:
RE: GSK: UK still 'attractive' post Brexit as it invests PS275m - BBC News
Of course a big pharma company isn't concerned, people still need medicine regardless of what state the economy is in. Additionally most of their companies value is in patents and IP.